Psychedelics Optimi Health enters $1.2M psilocybin distribution agreement The mushroom cultivator will be supplying a private client for clinical research purposes Rowan DunneMay 4, 2023
Psychedelics International psychedelics market to reach US$8.3B by 2027: ReportLinker The market was valued at US$4.83B this year and will rise with a CAGR of 14.5 per cent Rowan DunneApril 24, 2023
Psychedelics Optimi Health secures MDMA and psilocybin distribution agreement in Australia The company will supply Mind Medicine Australia with the substances, now considered designated therapies in the country Rowan DunneMarch 1, 2023